5-Bromo-2-Cyanopyridine CAS 97483-77-7 Puritas ≥99.0% (HPLC) Phosphate Tedizolid intermedia

Description:

Nomen chemicum: 5-Bromo-2-Cyanopyridine

CAS: 97483-77-7

Puritas: ≥99.0% (HPLC)

Aspectus: Off-White ad luteum pallidum pulveris

Intermedium Phosphatis Tedizolid (CAS: 856867-55-5) pro curatione ABSSSI

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Manufacturer Supple, Puritas, Commercial Productio
Nomen chemicum: 5-Bromo-2-Cyanopyridine
CAS: 97483-77-7

Chemical Properties:

Nomen chemicum 5-Bromo-2-Cyanopyridine
Synonyma 5-Bromo-2-Pyridinecarbonitrile;5-Bromopicolinonitrile
CAS Number 97483-77-7
CATTUS Number RF-PI610
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C6H3BrN2
M. Pondus 183.01
Liquescens punctum 128.0~132.0℃ (lit.)
Ferveret 100.0-110.0℃/3 mmHg (lit.)
Solubilitas Solutum in Methanol
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Off-White ut pallide Yellow pulveris
Puritas / Analysis Methodus ≥99.0% (HPLC)
Humor (KF) ≤0.50%
Totalis immunditias ≤1.0%
Test Standard Enterprise Standard
Consuetudinem Intermedia Phosphate Tedizolid (CAS: 856867-55-5)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.

commoda:

1

FAQ:

Applicatio:

5-Bromo-2-Cyanopyridine (CAS: 97483-77-7) est synthesis organica et media pharmaceutica, quae maxime adhiberi potest in investigationis laboratoria et processu chemico.5-Bromo-2-Cyanopyridine media est Phosphatis Tedizolidis (CAS: 856867-55-5).Phosphate Tedizolid novum anti-bacterial medicamentum a CUBISTA PHARMORUM comitatu enucleatum est.phosphas Tedizolid est prodrug Tedizolid.Post administrationem oralem vel intravenosam, phosphas Tedizolidarum ad Tedizolid per phosphatas convertitur.Tedizolid est secunda generatio antibioticorum oxazolidinonis, synthesis interdum inhibitorum.50S subunita ribosomes bacterial ligans, interdum synthesim inhibere potest et partes antibacterial agere.Die 20 Iunii 2014, Cibus et medicamentum Administration US (FDA) phosphas Tedizolidarum approbavit usui quodam bacterial-sensitivo adulto inducto adulta cute bacterial et contagios structurae cutis (ABSSSI), nomine artis SIVEXTRO.

Epistulam tuam hic scribe et mitte nobis